Suchergebnisse - "Cook, Gordon"

PubPharm (409)

11

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

enthalten in: Nature medicine | 2023

von Barnes, E. | Goodyear, C. | Willicombe, M. | +146

12

Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Mateos, M. | Rigaudeau, S. | Basu, S. | +14

13

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma : a consensus report of the European Myeloma Network

enthalten in: The Lancet. Oncology | 2023

von Ludwig, H. | Terpos, E. | van de Donk, N. | +26

14

Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma : results from the Myeloma UK (MUK) nine OPTIMUM trial

enthalten in: British journal of haematology | 2023

von Faustini, S. | Hall, A. | Brown, S. | +12

15

Management of patients with multiple myeloma and COVID-19 in the post pandemic era : a consensus paper from the European Myeloma Network (EMN)

enthalten in: Leukemia | 2023

von Terpos, E. | Musto, P. | Engelhardt, M. | +18

16

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma : A real-world multicentre UK retrospective analysis

enthalten in: British journal of haematology | 2023

von McMillan, A. | Basu, S. | Karunanithi, K. | +22

17

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial

enthalten in: British journal of haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +16

18

Optimizing the value of lenalidomide maintenance by extended genetic profiling : an analysis of 556 patients in the Myeloma XI trial

enthalten in: Blood | 2023

von Panopoulou, A. | Cairns, D. | Holroyd, A. | +13

CommentIn: Blood. 2023 Apr 6;141(14):1649-1650. - PMID 37022733

19

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Thompson, M. | Boccadoro, M. | Leleu, X. | +26

20

Diagnostic delay in multiple myeloma: the legacy of the COVID-19 pandemic.

enthalten in: ResearchSquare.com | 2023

von Carmichael, J. | Seymour, F. | Mcilroy, G. | +10